|
KIAA1826 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.88880000043746E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.375210E-03 |
| Normal-vs-Stage2 |
6.997900E-02 |
| Normal-vs-Stage3 |
8.73810002133268E-09 |
| Normal-vs-Stage4 |
1.07299999996258E-08 |
| Stage1-vs-Stage2 |
9.571000E-01 |
| Stage1-vs-Stage3 |
1.950700E-04 |
| Stage1-vs-Stage4 |
2.399300E-04 |
| Stage2-vs-Stage3 |
3.272400E-02 |
| Stage2-vs-Stage4 |
2.030100E-02 |
| Stage3-vs-Stage4 |
6.709400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00889999998799E-06 |
| Normal-vs-AfricanAmerican |
9.60679999999492E-05 |
| Normal-vs-Asian |
3.493600E-01 |
| Caucasian-vs-AfricanAmerican |
4.397400E-01 |
| Caucasian-vs-Asian |
5.057400E-01 |
| AfricanAmerican-vs-Asian |
3.481600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.40739999946405E-08 |
| Normal-vs-Female |
1.399390E-03 |
| Male-vs-Female |
1.678040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.283800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.353100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.06140000017052E-07 |
| Normal-vs-Age(81-100Yrs) |
2.118100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.631400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.844600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.792600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.234160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.755800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.658400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.972600E-01 |
| Normal-vs-Grade 2 |
1.297410E-03 |
| Normal-vs-Grade 3 |
2.80700000021561E-07 |
| Normal-vs-Grade 4 |
6.70330002616737E-09 |
| Grade 1-vs-Grade 2 |
3.797400E-01 |
| Grade 1-vs-Grade 3 |
8.832200E-02 |
| Grade 1-vs-Grade 4 |
1.049840E-02 |
| Grade 2-vs-Grade 3 |
1.625930E-02 |
| Grade 2-vs-Grade 4 |
2.210500E-04 |
| Grade 3-vs-Grade 4 |
5.362300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.120220E-01 |
| Normal-vs-ccB subtype |
4.03439999963062E-07 |
| ccA subtype-vs-ccB subtype |
2.08349999999413E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79639999999814E-05 |
| Normal-vs-N1 |
4.420200E-02 |
| N0-vs-N1 |
6.314200E-01 |
|
|
